COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 816: Articles 8151-8160  | Next

Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program
Rao, S., Lee, G. M., Razzaghi, H., Lorman, V., Mejias, A., Pajor, N. M., Thacker, D., Webb, R., Dickinson, K., Bailey, C., Jhaveri, R., Christakis, D. A., Bennett, T. D., Chen, Y., Forrest, C. B.
10.1101/2022.05.24.22275544 — Posted: 2022-05-25
Post-covid medical complaints after SARS-CoV-2 Omicron vs Delta variants -a prospective cohort study
Magnusson, K., Kristoffersen, D. T., Dell'Isola, A., Kiadaliri, A., Turkiewicz, A., Runhaar, J., Bierma-Zeinstra, S., Englund, M., Magnus, P. M., Kinge, J. M.
10.1101/2022.05.23.22275445 — Posted: 2022-05-25
Analysis of the genetic diversity of SARS-CoV-2 genomes carrying the Omicron B.1.1.529 mutation
Silva, B. W. C. d., Felix, P. T.
10.1101/2022.05.21.22275421 — Posted: 2022-05-25
Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation
Carlson, C., Adly, A., Bi, M., Cheng, Y., Morgan, D. O.
10.1101/2022.05.23.493138 — Posted: 2022-05-24
Bayesian Inference of Dependent Population Dynamics in Coalescent Models
Cappello, L., Kim, J., Palacios, J. A.
10.1101/2022.05.22.492976 — Posted: 2022-05-24
Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
Wali, L., Karbiener, M., Chou, S., Kovtunyk, V., Adonyi, A., Goesler, I., Contreras, X., Stoeva, D., Blaas, D., Stoeckl, J., Kreil, T. R., Gualdoni, G. A., Gorki, A.-D.
10.1101/2022.05.24.493068 — Posted: 2022-05-24
RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity
Angioni, R., Bonfanti, M., Caporale, N., Sanchez-Rodriguez, R., Munari, F., Savino, A., Buratto, D., Pagani, I., Bertoldi, N., Zanon, C., Ferrari, P., Ricciardelli, E., Putaggio, C., Ghezzi, S., Elli, F., Rotta, L., Iorio, F., Zonta, F., Cattelan, A., Vicenzi, E., Molon, B., Villa, C. E., Viola, A., Testa, G.
10.1101/2022.05.22.492693 — Posted: 2022-05-24
Incidence of Glomerulonephritis after SARS-CoV-2 mRNA Vaccination
Diebold, M., Locher, E., Boide, P., Enzler-Tschudy, A., Faivre, A., Fischer, I., Helmchen, B., Hopfer, H., Kim, M. J., Moll, S., Nanchen, G., Rotman, S., Saganas, C., Seeger, H., Kistler, A. D.
10.1101/2022.05.18.22275112 — Posted: 2022-05-24
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon, A., Huo, J., Nutalai, R., Dijokaite-Guraliuc, A., Zhou, D., Ginn, H. M., Sekvaraj, M., Liu, C., Mentzer, A. J., Supasa, P., Duyvesteyn, H. M. E., Das, R., Skelly, D., Ritter, T. G., Amini, A., Bibi, S., Adele, S., Johnson, S. A., Constantinides, B., Webster, H., Temperton, N., Klenerman, P., Barnes, E., Dunachie, S. J., Crook, D., Pollard, A. J., Lambe, T., Goulder, P., OPTIC consortium, , ISARIC4C consortium, , Fry, E. E., Mongkolsapaya, J., Ren, J., Stuart, D. I., Screaton, G. R.
10.1101/2022.05.21.492554 — Posted: 2022-05-23
Predictions of immunogenicity reveal potent SARS-CoV-2 CD8+ T-cell epitopes
Gfeller, D., Schmidt, J., Croce, G., Guillaume, P., Bobisse, S., Genolet, R., Queiroz, L., Cesbron, J., Racle, J., Harari, A.
10.1101/2022.05.23.492800 — Posted: 2022-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).